BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 33878349)

  • 1. Development and validation of a risk prediction model for high-risk adenomas at the time of first screening colonoscopy among screening aged Canadians.
    Sutherland RL; Boyne DJ; Jarada TN; Lix LM; Tinmouth J; Rabeneck L; Heitman SJ; Forbes N; Hilsden RJ; Brenner DR
    Prev Med; 2021 Jul; 148():106563. PubMed ID: 33878349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer risk factors in the detection of advanced adenoma and colorectal cancer.
    Stegeman I; de Wijkerslooth TR; Stoop EM; van Leerdam ME; Dekker E; van Ballegooijen M; Kuipers EJ; Fockens P; Kraaijenhagen RA; Bossuyt PM
    Cancer Epidemiol; 2013 Jun; 37(3):278-83. PubMed ID: 23491770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Test performance of immunologic fecal occult blood testing and sigmoidoscopy compared with primary colonoscopy screening for colorectal advanced adenomas.
    Khalid-de Bakker CA; Jonkers DM; Sanduleanu S; de Bruïne AP; Meijer GA; Janssen JB; van Engeland M; Stockbrügger RW; Masclee AA
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1563-71. PubMed ID: 21750209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a clinical score for predicting risk of adenoma at screening colonoscopy.
    Shaukat A; Church TR; Shanley R; Kauff ND; O'Brien MJ; Mills GM; Jordan PA; Allen JA; Kim A; Feld AD; Zauber AG; Winawer SJ
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):913-20. PubMed ID: 25800242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of the Asia Pacific Colorectal Screening (APCS) score in a Western population: An alternative screening tool.
    Corte C; Zhang L; Chen J; Westbury S; Shaw J; Yeoh KG; Leong R
    J Gastroenterol Hepatol; 2016 Feb; 31(2):370-5. PubMed ID: 26485170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal Cancer Incidence and Mortality After Removal of Adenomas During Screening Colonoscopies.
    Wieszczy P; Kaminski MF; Franczyk R; Loberg M; Kobiela J; Rupinska M; Kocot B; Rupinski M; Holme O; Wojciechowska U; Didkowska J; Ransohoff D; Bretthauer M; Kalager M; Regula J
    Gastroenterology; 2020 Mar; 158(4):875-883.e5. PubMed ID: 31563625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors Associated With Shorter Colonoscopy Surveillance Intervals for Patients With Low-Risk Colorectal Adenomas and Effects on Outcome.
    Anderson JC; Baron JA; Ahnen DJ; Barry EL; Bostick RM; Burke CA; Bresalier RS; Church TR; Cole BF; Cruz-Correa M; Kim AS; Mott LA; Sandler RS; Robertson DJ
    Gastroenterology; 2017 Jun; 152(8):1933-1943.e5. PubMed ID: 28219690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low risk of colorectal cancer and advanced adenomas more than 10 years after negative colonoscopy.
    Brenner H; Haug U; Arndt V; Stegmaier C; Altenhofen L; Hoffmeister M
    Gastroenterology; 2010 Mar; 138(3):870-6. PubMed ID: 19909750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermediate-risk patients with three to four small adenomas should be considered low risk for colorectal cancer screening.
    Pérez-Cuadrado-Robles E; Torrella-Cortés E; Bebia-Conesa P; Quesada-Vázquez N; Rodrigo-Agudo JL; Chacón-Martínez S; López-Martín A; Esteban-Delgado P; Pérez-Cuadrado-Martínez E; Pérez-Riquelme F
    Dig Endosc; 2016 May; 28(4):450-455. PubMed ID: 26538148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a clinical risk index for advanced colorectal neoplasia among a North American population of screening age.
    Ruco A; Stock D; Hilsden RJ; McGregor SE; Paszat LF; Saskin R; Rabeneck L
    BMC Gastroenterol; 2015 Nov; 15():162. PubMed ID: 26585867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Intensity Versus Low-Intensity Surveillance for Patients With Colorectal Adenomas: A Cost-Effectiveness Analysis.
    Meester RGS; Lansdorp-Vogelaar I; Winawer SJ; Zauber AG; Knudsen AB; Ladabaum U
    Ann Intern Med; 2019 Nov; 171(9):612-622. PubMed ID: 31546257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in Adenoma Detection Rates During the First 10 Years of the German Screening Colonoscopy Program.
    Brenner H; Altenhofen L; Kretschmann J; Rösch T; Pox C; Stock C; Hoffmeister M
    Gastroenterology; 2015 Aug; 149(2):356-66.e1. PubMed ID: 25911510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
    Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
    Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multivariable models for advanced colorectal neoplasms in screen-eligible individuals at low-to-moderate risk of colorectal cancer: towards improving colonoscopy prioritization.
    Murthy SK; Antonova L; Dube C; Benchimol EI; Le Gal G; Hae R; Burke S; Ramsay T; Rostom A
    BMC Gastroenterol; 2021 Oct; 21(1):383. PubMed ID: 34663234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Risk Prediction Index for Advanced Colorectal Neoplasia at Screening Colonoscopy.
    Schroy PC; Wong JB; O'Brien MJ; Chen CA; Griffith JL
    Am J Gastroenterol; 2015 Jul; 110(7):1062-71. PubMed ID: 26010311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential for prevention: a cohort study of colonoscopies and removal of adenomas in a FIT-based colorectal cancer screening programme.
    Larsen MB; Njor SH; Jensen TM; Ingeholm P; Andersen B
    Scand J Gastroenterol; 2019 Aug; 54(8):1008-1014. PubMed ID: 31397598
    [No Abstract]   [Full Text] [Related]  

  • 17. High-risk family colorectal cancer screening service in Ireland: Critical review of clinical outcomes.
    Walshe M; Moran R; Boyle M; Cretu I; Galvin Z; Swan V; Trikovic J; Farrell MP; Foy S; O'Brien L; Leyden J; Mulligan N; Fenlon H; Gallagher DJ; MacMathúna P
    Cancer Epidemiol; 2017 Oct; 50(Pt A):30-38. PubMed ID: 28783501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural history of colorectal adenomas: birth cohort analysis among 3.6 million participants of screening colonoscopy.
    Brenner H; Altenhofen L; Stock C; Hoffmeister M
    Cancer Epidemiol Biomarkers Prev; 2013 Jun; 22(6):1043-51. PubMed ID: 23632815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline Colonoscopy Findings Associated With 10-Year Outcomes in a Screening Cohort Undergoing Colonoscopy Surveillance.
    Lieberman D; Sullivan BA; Hauser ER; Qin X; Musselwhite LW; O'Leary MC; Redding TS; Madison AN; Bullard AJ; Thomas R; Sims KJ; Williams CD; Hyslop T; Weiss D; Gupta S; Gellad ZF; Robertson DJ; Provenzale D
    Gastroenterology; 2020 Mar; 158(4):862-874.e8. PubMed ID: 31376388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a scoring system to identify individuals at high risk for advanced colorectal neoplasms who should undergo colonoscopy screening.
    Tao S; Hoffmeister M; Brenner H
    Clin Gastroenterol Hepatol; 2014 Mar; 12(3):478-85. PubMed ID: 24022090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.